Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Nature Medicine|September 22, 2022
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphomaEmmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Nature Protocols|March 20, 2019
INFOGEST static in vitro simulation of gastrointestinal food digestionAndré Brodkorb, Lotti Egger, Marie Alminger, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Blood Advances|March 3, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphomaVincent Camus, Thierry Molina, Fabienne Desmots, et al.
The New England Journal of Medicine|September 6, 2018
Rituximab plus Lenalidomide in Advanced Untreated Follicular LymphomaFranck Morschhauser, Nathan H Fowler, Pierre Feugier, et al.
Haematologica|September 2, 2018
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphomaRémy Gressin, Nicolas Daguindau, Adrian Tempescul, et al.
Hemasphere|May 8, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA groupPierre Sesques, Guillaume Manson, Guillaume Cartron, et al.
Haematologica|November 30, 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA groupSylvain Carras, Alexia Torroja, Anouk Emadali, et al.
Pageof 28